211 related articles for article (PubMed ID: 24821728)
21. Histone deacetylase 3 (HDAC3) is recruited to target promoters by PML-RARalpha as a component of the N-CoR co-repressor complex to repress transcription in vivo.
Atsumi A; Tomita A; Kiyoi H; Naoe T
Biochem Biophys Res Commun; 2006 Jul; 345(4):1471-80. PubMed ID: 16730330
[TBL] [Abstract][Full Text] [Related]
22. The integrity of the charged pocket in the BTB/POZ domain is essential for the phenotype induced by the leukemia-associated t(11;17) fusion protein PLZF/RARalpha.
Puccetti E; Zheng X; Brambilla D; Seshire A; Beissert T; Boehrer S; Nürnberger H; Hoelzer D; Ottmann OG; Nervi C; Ruthardt M
Cancer Res; 2005 Jul; 65(14):6080-8. PubMed ID: 16024608
[TBL] [Abstract][Full Text] [Related]
23. Role of the histone deacetylase complex in acute promyelocytic leukaemia.
Lin RJ; Nagy L; Inoue S; Shao W; Miller WH; Evans RM
Nature; 1998 Feb; 391(6669):811-4. PubMed ID: 9486654
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive genomic screens identify a role for PLZF-RARalpha as a positive regulator of cell proliferation via direct regulation of c-MYC.
Rice KL; Hormaeche I; Doulatov S; Flatow JM; Grimwade D; Mills KI; Leiva M; Ablain J; Ambardekar C; McConnell MJ; Dick JE; Licht JD
Blood; 2009 Dec; 114(27):5499-511. PubMed ID: 19855079
[TBL] [Abstract][Full Text] [Related]
25. Aberrant chromatin remodeling by retinoic acid receptor alpha fusion proteins assessed at the single-cell level.
Qiu J; Huang Y; Chen G; Chen Z; Tweardy DJ; Dong S
Mol Biol Cell; 2007 Oct; 18(10):3941-51. PubMed ID: 17671166
[TBL] [Abstract][Full Text] [Related]
26. Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha.
Cheng GX; Zhu XH; Men XQ; Wang L; Huang QH; Jin XL; Xiong SM; Zhu J; Guo WM; Chen JQ; Xu SF; So E; Chan LC; Waxman S; Zelent A; Chen GQ; Dong S; Liu JX; Chen SJ
Proc Natl Acad Sci U S A; 1999 May; 96(11):6318-23. PubMed ID: 10339585
[TBL] [Abstract][Full Text] [Related]
27. RARalpha-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemia.
Guidez F; Parks S; Wong H; Jovanovic JV; Mays A; Gilkes AF; Mills KI; Guillemin MC; Hobbs RM; Pandolfi PP; de Thé H; Solomon E; Grimwade D
Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18694-9. PubMed ID: 18000064
[TBL] [Abstract][Full Text] [Related]
28. Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein.
Dong S; Zhu J; Reid A; Strutt P; Guidez F; Zhong HJ; Wang ZY; Licht J; Waxman S; Chomienne C; Chen Z; Zelent A; Chen SJ
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3624-9. PubMed ID: 8622986
[TBL] [Abstract][Full Text] [Related]
29. Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein.
David G; Alland L; Hong SH; Wong CW; DePinho RA; Dejean A
Oncogene; 1998 May; 16(19):2549-56. PubMed ID: 9627120
[TBL] [Abstract][Full Text] [Related]
30. Acute promyelocytic leukemia with a PLZF-RARalpha fusion protein.
Jansen JH; Löwenberg B
Semin Hematol; 2001 Jan; 38(1):37-41. PubMed ID: 11172538
[TBL] [Abstract][Full Text] [Related]
31. HDAC4 mediates transcriptional repression by the acute promyelocytic leukaemia-associated protein PLZF.
Chauchereau A; Mathieu M; de Saintignon J; Ferreira R; Pritchard LL; Mishal Z; Dejean A; Harel-Bellan A
Oncogene; 2004 Nov; 23(54):8777-84. PubMed ID: 15467736
[TBL] [Abstract][Full Text] [Related]
32. The impact of differential binding of wild-type RARalpha, PML-, PLZF- and NPM-RARalpha fusion proteins towards transcriptional co-activator, RIP-140, on retinoic acid responses in acute promyelocytic leukemia.
So CW; Dong S; So CK; Cheng GX; Huang QH; Chen SJ; Chan LC
Leukemia; 2000 Jan; 14(1):77-83. PubMed ID: 10637480
[TBL] [Abstract][Full Text] [Related]
33. Sequence-specific DNA binding and transcriptional regulation by the promyelocytic leukemia zinc finger protein.
Li JY; English MA; Ball HJ; Yeyati PL; Waxman S; Licht JD
J Biol Chem; 1997 Sep; 272(36):22447-55. PubMed ID: 9278395
[TBL] [Abstract][Full Text] [Related]
34. The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger, regulates 1,25-dihydroxyvitamin D(3)-induced monocytic differentiation of U937 cells through a physical interaction with vitamin D(3) receptor.
Ward JO; McConnell MJ; Carlile GW; Pandolfi PP; Licht JD; Freedman LP
Blood; 2001 Dec; 98(12):3290-300. PubMed ID: 11719366
[TBL] [Abstract][Full Text] [Related]
35. 8-CPT-cAMP/all-trans retinoic acid targets t(11;17) acute promyelocytic leukemia through enhanced cell differentiation and PLZF/RARα degradation.
Jiao B; Ren ZH; Liu P; Chen LJ; Shi JY; Dong Y; Ablain J; Shi L; Gao L; Hu JP; Ren RB; de Thé H; Chen Z; Chen SJ
Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3495-500. PubMed ID: 23382200
[TBL] [Abstract][Full Text] [Related]
36. Aberrant corepressor interactions implicated in PML-RAR(alpha) and PLZF-RAR(alpha) leukemogenesis reflect an altered recruitment and release of specific NCoR and SMRT splice variants.
Mengeling BJ; Phan TQ; Goodson ML; Privalsky ML
J Biol Chem; 2011 Feb; 286(6):4236-47. PubMed ID: 21131350
[TBL] [Abstract][Full Text] [Related]
37. The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene.
Lagger G; Doetzlhofer A; Schuettengruber B; Haidweger E; Simboeck E; Tischler J; Chiocca S; Suske G; Rotheneder H; Wintersberger E; Seiser C
Mol Cell Biol; 2003 Apr; 23(8):2669-79. PubMed ID: 12665570
[TBL] [Abstract][Full Text] [Related]
38. Retinoblastoma protein and the leukemia-associated PLZF transcription factor interact to repress target gene promoters.
Petrie K; Guidez F; Zhu J; Howell L; Owen G; Chew YP; Parks S; Waxman S; Licht J; Mittnacht S; Zelent A
Oncogene; 2008 Sep; 27(39):5260-6. PubMed ID: 18504436
[TBL] [Abstract][Full Text] [Related]
39. The Flt3 internal tandem duplication mutant inhibits the function of transcriptional repressors by blocking interactions with SMRT.
Takahashi S; McConnell MJ; Harigae H; Kaku M; Sasaki T; Melnick AM; Licht JD
Blood; 2004 Jun; 103(12):4650-8. PubMed ID: 14982881
[TBL] [Abstract][Full Text] [Related]
40. Activation of p53 transcriptional activity by SMRT: a histone deacetylase 3-independent function of a transcriptional corepressor.
Adikesavan AK; Karmakar S; Pardo P; Wang L; Liu S; Li W; Smith CL
Mol Cell Biol; 2014 Apr; 34(7):1246-61. PubMed ID: 24449765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]